NCT03674658View on ClinicalTrials.gov

Propafenone in the Treatment of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

August 17, 2021

Study Completion Date

August 17, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

Propafenone

oral, TID

Trial Locations (1)

Unknown

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

TSH Biopharm Corporation Limited

INDUSTRY

NCT03674658 - Propafenone in the Treatment of Atrial Fibrillation | Biotech Hunter | Biotech Hunter